Agilent Technologies
About: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Employees: 17,900
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
50% more call options, than puts
Call options by funds: $164M | Put options by funds: $109M
49% more first-time investments, than exits
New positions opened: 134 | Existing positions closed: 90
2% more funds holding
Funds holding: 1,034 [Q3] → 1,058 (+24) [Q4]
2.09% more ownership
Funds ownership: 86.18% [Q3] → 88.27% (+2.09%) [Q4]
4% less repeat investments, than reductions
Existing positions increased: 363 | Existing positions reduced: 377
8% less capital invested
Capital invested by funds: $36.6B [Q3] → $33.9B (-$2.79B) [Q4]
33% less funds holding in top 10
Funds holding in top 10: 12 [Q3] → 8 (-4) [Q4]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Jefferies Brandon Couillard 24% 1-year accuracy 6 / 25 met price target | 16%upside $116 | Hold Maintained | 21 Apr 2025 |
Wells Fargo Brandon Couillard 24% 1-year accuracy 6 / 25 met price target | 35%upside $135 | Overweight Maintained | 17 Apr 2025 |
Barclays Luke Sergott 28% 1-year accuracy 16 / 57 met price target | 15%upside $115 | Equal-Weight Maintained | 10 Apr 2025 |
Baird Catherine Schulte 0% 1-year accuracy 0 / 20 met price target | 59%upside $159 | Outperform Maintained | 27 Feb 2025 |
B of A Securities Derik De Bruin 35% 1-year accuracy 7 / 20 met price target | 56%upside $156 | Neutral Maintained | 27 Jan 2025 |
Financial journalist opinion
Based on 4 articles about A published over the past 30 days









